Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000790787 | SCV000227757 | pathogenic | not provided | 2012-07-02 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000003106 | SCV000487037 | likely pathogenic | Niemann-Pick disease, type C1 | 2016-09-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000003106 | SCV001233849 | pathogenic | Niemann-Pick disease, type C1 | 2023-11-09 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 1035 of the NPC1 protein (p.Ala1035Val). This variant is present in population databases (rs28942107, gnomAD 0.003%). This missense change has been observed in individual(s) with Niemann-Pick disease type C (PMID: 11479732, 16098014, 23183285; Invitae). ClinVar contains an entry for this variant (Variation ID: 2972). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt NPC1 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV000003106 | SCV002811480 | likely pathogenic | Niemann-Pick disease, type C1 | 2022-02-26 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000003106 | SCV000023264 | pathogenic | Niemann-Pick disease, type C1 | 2001-07-01 | no assertion criteria provided | literature only | |
Natera, |
RCV000003106 | SCV002095169 | pathogenic | Niemann-Pick disease, type C1 | 2021-05-06 | no assertion criteria provided | clinical testing |